Poseida Therapeutics, Inc.

New Filing
CIK: 0001661460·Biotechnology·DELAWARE·Filed: Aug 3, 2017
Total Offering

$15,000,000

Amount Sold

$11,160,002

Investors

16

First Sale

Jul 21, 2017

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2014
Non-Accredited Investors
No

Related Persons

NameRole
Nishan de Silva
Related Person
Eric Ostertag
Related Person
Lars Ekman
Related Person
Adrian Howd
Related Person
Robert Lyons
Related Person

Company

Poseida Therapeutics, Inc.

4242 Campus Point Court, Suite 700

San Diego, CA, 92121

858-242-1576

SEC Filing

0001661460-17-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free